
Augros Cosmetic (AUGR) | Financial Analysis & Statements
Augros Cosmetic Packaging | Small-cap | Consumer Cyclical
Augros Cosmetic Packaging | Small-cap | Consumer Cyclical
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
13.6M
Total Liabilities
10.3M
Shareholders Equity
3.3M
Debt to Equity
3.09
Cash Flow Metrics
Revenue & Profitability Trend
Augros Cosmetic Income Statement From 2019 to 2023
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 20.8M | 20.5M | 14.9M | 14.4M | 17.3M |
Cost of Goods Sold | 14.0M | 12.1M | 8.2M | 8.3M | 9.4M |
Gross Profit | 6.8M | 8.3M | 6.7M | 6.1M | 7.9M |
Gross Margin % | 32.7% | 40.7% | 45.0% | 42.2% | 45.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | 2.4M | 2.5M | 1.9M | 2.0M | 2.2M |
Total Operating Expenses | 2.4M | 2.5M | 1.9M | 2.0M | 2.2M |
Operating Income | 61.4K | 802.3K | 88.2K | -496.4K | 490.2K |
Operating Margin % | 0.3% | 3.9% | 0.6% | -3.5% | 2.8% |
Non-Operating Items | |||||
Interest Income | - | - | 0 | 7 | - |
Interest Expense | 290.4K | 84.7K | 51.8K | 39.0K | 47.2K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -769.7K | 619.9K | 37.3K | -670.4K | 678.2K |
Income Tax | - | - | - | - | - |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -769.7K | 619.9K | 37.3K | -670.4K | 678.2K |
Net Margin % | -3.7% | 3.0% | 0.2% | -4.7% | 3.9% |
Key Metrics | |||||
EBITDA | 961.4K | 1.7M | 931.7K | 305.4K | 1.2M |
EPS (Basic) | €-0.54 | - | €0.03 | €-0.47 | €0.48 |
EPS (Diluted) | €-0.54 | - | €0.03 | €-0.47 | €0.48 |
Basic Shares Outstanding | 1425402 | 1441644 | 1243833 | 1426411 | 1412958 |
Diluted Shares Outstanding | 1425402 | - | 1243833 | 1426411 | 1412958 |
Income Statement Trend
Augros Cosmetic Balance Sheet From 2019 to 2023
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 742.8K | 1.8M | 898.1K | 3.6M | 169.7K |
Short-term Investments | 59.7K | 66.2K | 59.6K | 55.5K | 79.9K |
Accounts Receivable | 2.6M | 1.3M | 890.2K | 1.6M | 1.8M |
Inventory | 1.8M | 2.2M | 1.5M | 1.1M | 1.2M |
Other Current Assets | 1 | 1 | - | 1 | - |
Total Current Assets | 8.3M | 7.7M | 5.0M | 7.6M | 4.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 10.5M | 4.2M | 4.8M | 131.3K | 123.5K |
Goodwill | 546.9K | 490.8K | 493.8K | 500.7K | 499.8K |
Intangible Assets | 59.1K | 3.0K | 6.0K | 12.9K | 12.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | 4.2K | 8.3K | 12.5K | 16.7K |
Total Non-Current Assets | 6.4M | 5.9M | 5.7M | 5.6M | 5.9M |
Total Assets | 14.7M | 13.6M | 10.8M | 13.2M | 10.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 5.8M | 5.1M | 2.5M | 2.6M | 2.7M |
Short-term Debt | 3.7M | 3.6M | 4.3M | 399.7K | 14.6K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 50.4K | 77.0K | 700 | 91.9K | 1.7K |
Total Current Liabilities | 11.4M | 10.1M | 8.1M | 5.2M | 4.6M |
Non-Current Liabilities | |||||
Long-term Debt | 276 | 276 | 276 | 5.3M | 2.0M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 1 | - | - | -1 | 3 |
Total Non-Current Liabilities | 772.4K | 150.3K | 276 | 5.4M | 2.1M |
Total Liabilities | 12.1M | 10.3M | 8.1M | 10.5M | 6.7M |
Equity | |||||
Common Stock | 200.0K | 200.0K | 200.0K | 200.0K | 200.0K |
Retained Earnings | -782.9K | -13.2K | -633.1K | -670.4K | -5.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.5M | 3.3M | 2.7M | 2.7M | 3.3M |
Key Metrics | |||||
Total Debt | 3.7M | 3.6M | 4.3M | 5.7M | 2.0M |
Working Capital | -3.1M | -2.5M | -3.0M | 2.4M | -472.7K |
Balance Sheet Composition
Augros Cosmetic Cash Flow Statement From 2019 to 2023
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -769.7K | 619.9K | 37.3K | -670.4K | 678.2K |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -509.2K | 1.0M | -1.2M | 258.3K | -11.7K |
Operating Cash Flow | -1.3M | 1.7M | -1.1M | -408.0K | 670.7K |
Investing Activities | |||||
Capital Expenditures | -1.2M | -417.0K | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | -628.4K | -442.7K | -232.0K | -727.8K |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -1.2M | -1.0M | -442.7K | -232.0K | -702.8K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 1.4M | 173.2K | - | 250.0K | 866.2K |
Debt Repayment | -1.2M | -777.3K | -1.5M | -795.0K | -1.0M |
Financing Cash Flow | 137.0K | -604.2K | -1.5M | 3.6M | -132.1K |
Free Cash Flow | -1.2M | 1.6M | -910.1K | 108.0K | 837.1K |
Net Change in Cash | -2.3M | 3.3K | -3.1M | 2.9M | -164.2K |
Cash Flow Trend
Augros Cosmetic Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.35
Price to Book
13.95
Price to Sales
0.54
Profitability Ratios
Profit Margin
-17.68%
Operating Margin
-22.61%
Return on Equity
-139.28%
Return on Assets
-6.65%
Financial Health
Current Ratio
0.85
Debt to Equity
696.58
Beta
-0.06
Per Share Data
EPS (TTM)
€-1.78
Book Value per Share
€0.43
Revenue per Share
€11.15
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
augr | 8.5M | 15.35 | 13.95 | -139.28% | -17.68% | 696.58 |
Verallia S.A | 3.2B | 17.06 | 3.57 | 19.91% | 5.25% | 253.82 |
Groupe Guillin | 570.3M | 9.55 | 0.90 | 9.83% | 6.86% | 14.02 |
Gascogne S.A | 90.3M | 8.21 | 0.42 | -0.31% | -0.16% | 127.87 |
TFF | 357.7M | 8.97 | 0.72 | 6.18% | 7.22% | 75.95 |
LVMH Moët Hennessy | 245.3B | 22.43 | 3.76 | 16.96% | 13.26% | 59.37 |
Financial data is updated regularly. All figures are in the company's reporting currency.